HH Biotechnology Holdings Company (HHBT)

0.0003 0.0000 (0.00%) As of 01:50PM EDT. Market open.

HH Biotechnology Holdings Company

President Building
C Site, 25-26 Floors No. 69 Heping North Street Heping District
Shenyang 110003
China
86 24 2281 3888
https://www.greatchinaholdings.com

Sector(s): Real Estate
Industry: Real Estate Services
Full-time employees: 121

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Sheng Jiang	Chief Executive Officer and Director	N/A	N/A	N/A
Ms. Li Rong Wang	Chief Financial Officer	12.39k	N/A	1963
Liang Zou	Vice President of Operations	N/A	N/A	N/A
Mr. Yee Kwa Tang	Investor Relations Officer	N/A	N/A	N/A
Sasaki Koji	Vice President of Marketing	N/A	N/A	N/A

Amounts are as of 31 December 2008, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016. HH Biotechnology Holdings Company was incorporated in 1987 and is headquartered in Shenyang, the People's Republic of China.

Corporate governance

HH Biotechnology Holdings Company’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.